NUMD (Nu-Med Plus) Cyclically Adjusted PB Ratio: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nu-Med Plus Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nu-Med Plus  (OTCPK:NUMD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Nu-Med Plus Cyclically Adjusted PB Ratio Related Terms


Nu-Med Plus Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Nu-Med Plus's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nu-Med Plus Cyclically Adjusted PB Ratio Chart

Nu-Med Plus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nu-Med Plus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NUMD vs SSKN, ODYY, NUWE: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Nu-Med Plus's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nu-Med Plus Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nu-Med Plus's Cyclically Adjusted PB Ratio falls into.



Nu-Med Plus Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Nu-Med Plus's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Nu-Med Plus's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.003/330.2130*330.2130
=-0.003

Current CPI (Mar. 2026) = 330.2130.

Nu-Med Plus Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.015 241.018 0.021
201609 -0.004 241.428 -0.005
201612 -0.119 241.432 -0.163
201703 -0.001 243.801 -0.001
201706 -0.003 244.955 -0.004
201709 0.001 246.819 0.001
201712 0.002 246.524 0.003
201803 -0.001 249.554 -0.001
201806 -0.001 251.989 -0.001
201809 0.005 252.439 0.007
201812 0.001 251.233 0.001
201903 -0.005 254.202 -0.006
201906 -0.007 256.143 -0.009
201909 -0.007 256.759 -0.009
201912 -0.008 256.974 -0.010
202003 -0.008 258.115 -0.010
202006 0.008 257.797 0.010
202009 0.004 260.280 0.005
202012 0.009 260.474 0.011
202103 0.002 264.877 0.002
202106 0.000 271.696 0.000
202109 -0.001 274.310 -0.001
202112 -0.002 278.802 -0.002
202203 -0.002 287.504 -0.002
202206 -0.003 296.311 -0.003
202209 -0.003 296.808 -0.003
202212 -0.001 296.797 -0.001
202303 -0.001 301.836 -0.001
202306 -0.001 305.109 -0.001
202309 -0.002 307.789 -0.002
202312 -0.002 306.746 -0.002
202403 -0.002 312.332 -0.002
202406 -0.002 314.175 -0.002
202409 -0.002 315.301 -0.002
202412 -0.003 315.605 -0.003
202503 -0.003 319.799 -0.003
202506 -0.003 322.561 -0.003
202509 -0.003 324.800 -0.003
202512 -0.003 324.054 -0.003
202603 -0.003 330.213 -0.003

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nu-Med Plus Business Description

Address 640 Belle Terre Road, Building 2 E Port, Jefferson, NY, USA, 11777
Nu-Med Plus Inc is a medical device company engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems, and the medical community throughout the world. It is currently working to locate a merger partner that will be able to fund the final development of these products.